mifepristone has been researched along with levonorgestrel in 90 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.11) | 18.7374 |
| 1990's | 16 (17.78) | 18.2507 |
| 2000's | 43 (47.78) | 29.6817 |
| 2010's | 26 (28.89) | 24.3611 |
| 2020's | 4 (4.44) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Elstein, M; Russell, J; Webb, AM | 1 |
| Haspels, AA | 2 |
| Joosten, JW; Kloosterboer, HJ; Schoonen, WG | 1 |
| Gordon, K; Heikinheimo, O; Hodgen, GD; Williams, RF | 1 |
| Murphy, AA; Parthasarathy, S; Roberts, CP; Santanam, N | 2 |
| Gibbons, WE; Gordon, K; Heikinheimo, O; Hodgen, GD; Hsiu, JG; Kim, S; Williams, RF | 1 |
| Goodman, AL; Greb, RR; Heikinheimo, O; Hodgen, GD; Williams, RF | 1 |
| Blye, RP; Cessac, JW; Kim, HK; Rao, PN | 1 |
| Xiao, B | 1 |
| Webb, AM | 2 |
| von Hertzen, H | 1 |
| Cheng, L; Ezcurra, E; Gülmezoglu, AM; Van Look, PF | 1 |
| Ho, PC | 1 |
| Bártfai, G | 1 |
| Chen, J; Cheng, L; Glasier, A; Ren, F; Wang, A; Zhu, H | 1 |
| Wertheimer, RE | 1 |
| Allan, GF; Campen, CA; Combs, DW; Haynes-Johnson, D; Hodgen, G; Hutchins, A; Kiddoe, M; Kraft, P; Lai, M; Lombardi, E; Palmer, S; Pedersen, P; Rybczynski, P | 1 |
| Bygdeman, M; Danielsson, KG; Marions, L | 1 |
| Glasier, A | 2 |
| Campos Campos, N; Castillo Portales, S; López De Castro, F; Rodríguez Alcalá, F | 1 |
| Wang, C; Wang, Y; Wu, S | 1 |
| Croxatto, HB; Devoto, L; Durand, M; Ezcurra, E; Larrea, F; Nagle, C; Ortiz, ME; Vantman, D; Vega, M; von Hertzen, H | 1 |
| Bigler, G; Spycher, C | 1 |
| Gupta, JA | 1 |
| Waxman, BF | 1 |
| Couchenour, RL; Wanner, MS | 1 |
| Critchley, HO; Davie, JE; Glasier, AF; Kelly, RW; Wang, H | 1 |
| Agostini, MC; Bartlewski, PM; Chedrese, PJ; Feyles, V; Swan, CL; Urban, RJ | 1 |
| Christow, A; Gemzell-Danielsson, K; Sun, X | 1 |
| García-Becerra, R; Gutiérrez-Sagal, R; Pasapera, AM; Savouret, JF; Ulloa-Aguirre, A | 1 |
| Ashok, PW; Flett, GM; Melvin, L; Stalder, C; Templeton, A; Wagaarachchi, PT | 1 |
| Gemzell Danielsson, K; Hultenby, K; Lindell, I; Marions, L; Ståbi, B; Sun, X | 1 |
| Toivonen, J | 1 |
| Andrade, AT | 1 |
| Lo, SS | 1 |
| Apter, D; Bártfai, G; Chen, J; Cheng, W; Ding, J; Gemzell-Danielsson, K; Khomassuridze, A; Kirkman, R; Lüdicke, F; Mittal, S; Ng, E; Oyunbileg, A; Peregoudov, A; Piaggio, G; Pretnar-Darovec, A; Song, S; von Hertzen, H; Wu, S | 1 |
| Wu, SC; Xiao, BL | 1 |
| Piaggio, G; von Hertzen, H | 1 |
| Bygdeman, M; Cekan, SZ; Gemzell-Danielsson, K; Marions, L | 1 |
| Berlanda, N; Fedele, L | 1 |
| Croxatto, HB; d'Arcangues, C; Fuentealba, B; Massai, MR; Pavez, M | 1 |
| Cheng, L; Ezcurra, E; Gülmezoglu, AM; Look, PF; Oel, CJ; Piaggio, G | 1 |
| Ashok, PW; Flett, GM; Hamoda, H; Templeton, A | 1 |
| Ashok, PW; Flett, GM; Hamoda, H; Kennedy, E; Stalder, C; Templeton, A | 1 |
| Amant, F; Berteloot, P; De Greef, I; Deprest, J; Timmerman, D | 1 |
| Shorto, R | 1 |
| Bastianelli, C; Di Miscia, A; Farris, M | 1 |
| Baird, DT; Critchley, HO; Dada, K; Elton, R; Glasier, AF; Ho, PC; Lakha, F; Van der Spuy, ZM; Williams, AR | 1 |
| Bentin-Ley, U; Gemzell-Danielsson, K; Hambiliki, F; Lalitkumar, PG; Lalitkumar, S; Meng, CX; Stavreus-Evers, A | 1 |
| Andersson, KL; Bentin-Ley, U; Gemzell-Danielsson, K; Lalitkumar, PG; Meng, CX | 1 |
| Cheng, L; Ezcurra, E; Gülmezoglu, AM; Piaggio, G; Van Look, PF | 1 |
| Grillo, CA; Libertun, C; Nicola, AF; Pietranera, L; Piroli, GG; Rey-Roldán, EB | 1 |
| Bi, HC; Chen, X; Huang, M; Huang, ZY; Tang, C; Zhong, GP | 1 |
| Boesch, C; Bronner, C; Hecker, M; Jourdain, M; Schini-Kerth, VB; Zerr-Fouineau, M | 1 |
| Jaeger, R; Moe, BT; Orbo, A; Sager, G; Vereide, AB | 1 |
| Amaliev, G | 1 |
| Benagiano, G; von Hertzen, H | 1 |
| Agarwal, N; Kriplani, A; Kulshrestha, V; Lal, S; Sharma, M | 1 |
| Cheng, L; Cleland, K; Raymond, E; Trussell, J; Zhu, H | 1 |
| Croxatto, HB; Henríquez, SP; Munroe, DJ; Noe, G; Quezada, M; Salvatierra, AM; Tapia-Pizarro, AA; Vargas, MF; Velasquez, LA | 1 |
| Bouchard, P | 1 |
| Jansson, A; Sivik, T | 1 |
| Martinez, AM; Thomas, MA | 1 |
| Che, Y; Cheng, L; Gülmezoglu, AM | 1 |
| Manyonda, I; Talaulikar, VS | 1 |
| Batur, P | 1 |
| Cheng, L; Gemzell-Danielsson, K; Rabe, T | 1 |
| Bastianelli, C; Benagiano, G; Brosens, I; Farris, M | 1 |
| Ho, PC; Li, HW; Lo, SS | 1 |
| Friedlander, E; Kaneshiro, B | 1 |
| Najera, DB | 1 |
| Abraham, T; Arian, SE; Bartels, CB; Cayton, KC; Chuong, FS; Holthouser, K; Segars, JH | 1 |
| Centini, G; Kashani, BN; Morelli, SS; Petraglia, F; Weiss, G | 1 |
| Brockmeier, EK; Denslow, ND; Leusch, FD; Scott, PD | 1 |
| Chen, Y; Shi, X | 1 |
| Che, Y; Chen, K; Cheng, L; Shen, J; Showell, E | 2 |
| Gemzell-Danielsson, K; Kopp Kallner, H; Papaikonomou, K; Söderdahl, F | 1 |
| Badmus, OO; Olatunji, LA | 1 |
| Frisendahl, C; Gemzell-Danielsson, K; Papaikonomou, K; Williams, ARW | 1 |
| Barrios-Hernández, AE; Durand-Carbajal, M; Larrea, F; Vega, CC | 1 |
| Dong, G; Li, Y; Ma, Q; Mu, Y; Song, S; Yang, L; Zhu, H | 1 |
| Ma, R; Mao, H; Wang, L; Xu, H; Zhang, L; Zhao, R; Zheng, Y | 1 |
33 review(s) available for mifepristone and levonorgestrel
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Emergency contraception: a review.
Topics: Contraceptives, Oral, Combined; Contraceptives, Postcoital; Emergencies; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Mifepristone | 1994 |
Trends in steroid contraceptive research.
Topics: Contraception; Contraceptives, Oral, Synthetic; Drug Delivery Systems; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Mifepristone; Norandrostanes | 1997 |
Research on mifepristone and levonorgestrel in comparison with the Yuzpe regimen.
Topics: Abortifacient Agents, Steroidal; Clinical Trials as Topic; Contraceptives, Postcoital; Drug Therapy, Combination; Emergencies; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Mifepristone; Norgestrel; Pregnancy; Pregnancy, Unwanted; Progesterone Congeners; World Health Organization | 1998 |
Interventions for emergency contraception.
Topics: Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Mifepristone | 2000 |
Emergency contraception: methods and efficacy.
Topics: Contraceptives, Oral, Combined; Contraceptives, Postcoital; Drug Administration Schedule; Female; Health Services Accessibility; Humans; Intrauterine Devices; Levonorgestrel; Mifepristone | 2000 |
Emergency postcoital contraception.
Topics: Abortifacient Agents; Adolescent; Adult; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Decision Making; Drug Administration Schedule; Drug Therapy, Combination; Emergency Treatment; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation-Inducing Agents; Mifepristone; Time Factors | 2000 |
[Knowledge about "morning-after pill" should be spread to all women. Comments on meta-analysis of postcoital contraception].
Topics: Contraceptives, Postcoital; Evidence-Based Medicine; Family Planning Services; Female; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Meta-Analysis as Topic; Mifepristone; Multicenter Studies as Topic; Randomized Controlled Trials as Topic | 2000 |
Emergency contraception.
Topics: Adolescent; Adult; Contraceptives, Postcoital; Female; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Humans; Levonorgestrel; Mifepristone; Time Factors | 2000 |
[After levonorgestrel, will mifepristone (RU486) be the next day-after pill?].
Topics: Contraceptive Agents, Female; Contraceptives, Postcoital, Synthetic; Female; Humans; Levonorgestrel; Mifepristone | 2001 |
Mechanism of action of hormonal preparations used for emergency contraception: a review of the literature.
Topics: Animals; Contraceptives, Postcoital; Estrogens; Ethinyl Estradiol; Female; Hormone Antagonists; Humans; Levonorgestrel; Mifepristone; Pregnancy; Progestins | 2001 |
[Postcoital emergency contraception].
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral, Combined; Contraceptives, Postcoital, Synthetic; Contraindications; Danazol; Drug Approval; Estrogen Antagonists; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Mifepristone; Progesterone Congeners; Switzerland | 2001 |
Hormonal emergency contraception.
Topics: Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Hormonal; Danazol; Drug Administration Schedule; Female; Humans; Levonorgestrel; Mifepristone; Nausea; Pregnancy; Vomiting | 2002 |
Emergency contraception.
Topics: Contraceptives, Oral, Combined; Contraceptives, Postcoital; Ethinyl Estradiol; Female; Health Services Accessibility; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Mifepristone; Risk Factors; Therapeutic Equivalency | 2002 |
Levonorgestrel and mifepristone in emergency contraception.
Topics: Clinical Trials as Topic; Contraceptives, Postcoital, Synthetic; Female; Humans; Levonorgestrel; Mifepristone; Pregnancy; Pregnancy Rate; Pregnancy, Unwanted; Random Allocation; Time Factors | 2003 |
Emerging drugs for endometriosis.
Topics: Adult; Animals; Anti-Inflammatory Agents; Aromatase Inhibitors; Contraceptives, Oral, Hormonal; Cytokines; Danazol; Endometriosis; Estradiol; Estrogen Receptor Modulators; Female; Gestrinone; Gonadotropin-Releasing Hormone; Hormone Antagonists; Hormone Replacement Therapy; Humans; Infertility, Female; Levonorgestrel; Mifepristone; Ovary; Ovulation; Pregnancy; Progestins; Randomized Controlled Trials as Topic | 2004 |
Interventions for emergency contraception.
Topics: Contraception, Postcoital; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Mifepristone; Randomized Controlled Trials as Topic | 2004 |
Interventions for emergency contraception.
Topics: Contraception, Postcoital; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Mifepristone; Randomized Controlled Trials as Topic | 2008 |
Ectopic pregnancy and emergency contraceptive pills: a systematic review.
Topics: Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Mifepristone; Pregnancy; Pregnancy, Ectopic | 2010 |
Current and future medical treatments for menometrorrhagia during the premenopause.
Topics: Adolescent; Adult; Contraceptives, Oral; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Levonorgestrel; Menorrhagia; Metrorrhagia; Mifepristone; Norpregnadienes; Polyps; Premenopause; Progestins; Randomized Controlled Trials as Topic; Receptors, Progesterone; Uterine Neoplasms | 2011 |
Ulipristal acetate as an emergency contraceptive agent.
Topics: Administration, Oral; Animals; Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Mifepristone; Norpregnadienes; Receptors, Progesterone; Time Factors | 2012 |
Interventions for emergency contraception.
Topics: Contraception, Postcoital; Contraceptives, Postcoital; Drug Administration Schedule; Female; Humans; Levonorgestrel; Mifepristone; Norpregnadienes; Randomized Controlled Trials as Topic | 2012 |
Progesterone and progesterone receptor modulators in the management of symptomatic uterine fibroids.
Topics: Endometrium; Estrenes; Female; Hormone Antagonists; Humans; Hyperplasia; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Receptors, Progesterone | 2012 |
Emergency contraception: separating fact from fiction.
Topics: Abortion, Induced; Contraception, Postcoital; Counseling; Crime Victims; Female; Hospitals; Humans; Intrauterine Devices, Copper; Levonorgestrel; Mifepristone; Nonprescription Drugs; Norpregnadienes; Obesity; Practice Patterns, Physicians'; Pregnancy; Pregnancy, Unplanned; Sex Offenses; United States | 2012 |
Selective progesterone receptor modulators: an update.
Topics: Adenomyosis; Animals; Clinical Trials as Topic; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Postcoital; Endometriosis; Estrenes; Female; Hormone Antagonists; Humans; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Receptors, Progesterone; Uterine Neoplasms | 2014 |
Emergency contraception.
Topics: Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Female; Health Knowledge, Attitudes, Practice; Humans; Intrauterine Devices, Copper; Levonorgestrel; Mifepristone; Norpregnadienes; Time Factors | 2014 |
Therapeutic Options for Unscheduled Bleeding Associated with Long-Acting Reversible Contraception.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraception; Doxycycline; Female; Hormone Antagonists; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Matrix Metalloproteinase Inhibitors; Mifepristone; Practice Guidelines as Topic; Time Factors; Tranexamic Acid; Uterine Hemorrhage | 2015 |
Emergency contraception: Focus on the facts.
Topics: Contraception; Contraception, Postcoital; Contraceptives, Oral, Hormonal; Cyclooxygenase Inhibitors; Female; Health Services Accessibility; Humans; Intrauterine Devices; Levonorgestrel; Meloxicam; Mifepristone; Norpregnadienes; Ovulation Inhibition; Pregnancy; Thiazines; Thiazoles | 2016 |
An Evidence-based Approach to the Medical Management of Fibroids: A Systematic Review.
Topics: Androgens; Aromatase Inhibitors; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Curcumin; Delayed-Action Preparations; Drugs, Chinese Herbal; Estradiol; Estrenes; Estrogen Receptor Antagonists; Evidence-Based Medicine; Female; Fulvestrant; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Neoadjuvant Therapy; Norpregnadienes; Oximes; Plant Extracts; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tea; Uterine Myomectomy; Uterine Neoplasms; Vitamin D; Vitamins | 2016 |
Role of Medical Management for Uterine Leiomyomas.
Topics: Antifibrinolytic Agents; Aromatase Inhibitors; Cabergoline; Cholecalciferol; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Danazol; Dopamine Agonists; Ergolines; Estrenes; Estrogen Antagonists; Female; Gestrinone; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Patient Care Planning; Selective Estrogen Receptor Modulators; Somatostatin; Tranexamic Acid; Uterine Neoplasms; Vitamins | 2016 |
Interventions for emergency contraception.
Topics: Contraception, Postcoital; Contraceptives, Postcoital; Drug Administration Schedule; Estradiol; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Mifepristone; Norpregnadienes; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Unsafe Sex | 2017 |
Interventions for emergency contraception.
Topics: Contraception, Postcoital; Contraceptives, Postcoital; Drug Administration Schedule; Estradiol; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Mifepristone; Norpregnadienes; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Unsafe Sex | 2019 |
Efficacy and safety of different subsequent therapies after fertility preserving surgery for endometriosis: A systematic review and network meta-analysis.
Topics: Danazol; Endometriosis; Female; Gestrinone; Humans; Leuprolide; Levonorgestrel; Mifepristone; Network Meta-Analysis | 2023 |
18 trial(s) available for mifepristone and levonorgestrel
| Article | Year |
|---|---|
Comparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Danazol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Middle Aged; Mifepristone; Nausea; Pregnancy; Treatment Outcome; Vomiting | 1992 |
Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Double-Blind Method; Drug Implants; Female; Hormone Antagonists; Humans; Levonorgestrel; Mifepristone; Placebos; Progesterone; Time Factors; Uterine Hemorrhage | 2000 |
[A randomized, double-blind, multicentre study on comparing levonorgestrel and mifepristone for emergency contraception].
Topics: Adult; Contraception; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Synthetic; Double-Blind Method; Female; Follow-Up Studies; Humans; Levonorgestrel; Mifepristone | 1999 |
Administration of an antiprogesterone up-regulates estrogen receptors in the endometrium of women using Norplant: a pilot study.
Topics: Biopsy; Contraceptives, Oral, Synthetic; Drug Interactions; Endometrium; Female; Hormone Antagonists; Humans; Immunohistochemistry; Levonorgestrel; Mifepristone; Pilot Projects; Progesterone; Prospective Studies; Receptors, Estrogen; Receptors, Progesterone; Single-Blind Method; Statistics, Nonparametric; Up-Regulation; Uterine Hemorrhage | 2002 |
A randomised study comparing a low dose of mifepristone and the Yuzpe regimen for emergency contraception.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Postcoital, Synthetic; Emergencies; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Mifepristone; Ovulation; Patient Satisfaction; Pregnancy; Treatment Outcome | 2002 |
Emergency contraception with mifepristone and levonorgestrel: mechanism of action.
Topics: Adult; Biopsy, Needle; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Synthetic; Dose-Response Relationship, Drug; Drug Administration Schedule; Emergencies; Endometrium; Female; Humans; Levonorgestrel; Menstruation; Mifepristone; Treatment Outcome | 2002 |
Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial.
Topics: Adult; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Synthetic; Double-Blind Method; Drug Administration Schedule; Emergencies; Female; Humans; Levonorgestrel; Mifepristone; World Health Organization | 2002 |
[Development of serial clinical study on mifepristone used as contraception].
Topics: Adult; Contraception; Contraceptives, Oral; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Mifepristone; Pregnancy; Pregnancy Rate | 2003 |
Effect of emergency contraception with levonorgestrel or mifepristone on ovarian function.
Topics: Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Synthetic; Female; Glucuronides; Humans; Levonorgestrel; Luteal Phase; Luteinizing Hormone; Mifepristone; Ovary | 2004 |
Effect of intermittent treatment with mifepristone on bleeding patterns in Norplant implant users.
Topics: Administration, Oral; Adult; Contraceptive Agents, Female; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Levonorgestrel; Mifepristone; Pregnancy; Prospective Studies; Treatment Outcome; Uterine Hemorrhage | 2004 |
Mifepristone versus the Yuzpe regimen (PC4) for emergency contraception.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Postcoital, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Mifepristone; Patient Satisfaction; Surveys and Questionnaires; Treatment Outcome | 2004 |
A randomized trial of mifepristone (10 mg) and levonorgestrel for emergency contraception.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Postcoital, Synthetic; Humans; Levonorgestrel; Logistic Models; Mifepristone; Patient Satisfaction | 2004 |
A novel estrogen-free oral contraceptive pill for women: multicentre, double-blind, randomized controlled trial of mifepristone and progestogen-only pill (levonorgestrel).
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Double-Blind Method; Endometrium; Female; Humans; Levonorgestrel; Menorrhagia; Mifepristone; Ovary; Ultrasonography; Uterus | 2007 |
Efficacy of mifepristone in reducing intermenstrual vaginal bleeding in users of the levonorgestrel intrauterine system.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Middle Aged; Mifepristone; Patient Satisfaction; Prospective Studies; Vagina; Young Adult | 2010 |
Effect of single post-ovulatory administration of levonorgestrel on gene expression profile during the receptive period of the human endometrium.
Topics: Contraceptive Agents, Female; Endometrium; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; Levonorgestrel; Luteal Phase; Menstrual Cycle; Mifepristone; Progesterone; Reproducibility of Results; Transcriptome | 2012 |
Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control - a randomized controlled trial.
Topics: Adult; Contraceptive Agents, Female; Double-Blind Method; Female; Hormone Antagonists; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Mifepristone; Prospective Studies; Young Adult | 2018 |
Effects of the levonorgestrel intrauterine system on the endometrium after long-term exposure to mifepristone: Secondary outcomes of a randomized controlled trial.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Mifepristone; Sweden; Young Adult | 2020 |
Analysis of the Endometrial Transcriptome at the Time of Implantation in Women Receiving a Single Post-Ovulatory Dose of Levonorgestrel or Mifepristone.
Topics: Adult; Contraceptives, Postcoital, Hormonal; Embryo Implantation; Endometrium; Female; Humans; Levonorgestrel; Mifepristone; Ovulation; Time Factors; Transcriptome; Young Adult | 2020 |
39 other study(ies) available for mifepristone and levonorgestrel
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines.
Topics: Breast Neoplasms; Carcinoma; Cell Division; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Estrenes; Estrogen Antagonists; Female; Furans; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Tumor Cells, Cultured | 1995 |
Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
Topics: Analysis of Variance; Androstenedione; Animals; Contraceptive Agents, Female; Estradiol; Female; Follicle Stimulating Hormone; Hypothalamus; Levonorgestrel; Luteinizing Hormone; Macaca fascicularis; Menstruation-Inducing Agents; Mifepristone; Ovarian Follicle; Ovary; Ovulation; Progesterone; Progesterone Congeners; Progestins | 1996 |
The effect of RU 486 and related compounds on cultured macrophage differentiation and function.
Topics: Antioxidants; Cell Adhesion; Cell Count; Cell Differentiation; Cell Line; Dexamethasone; Fluorescence; Humans; Levonorgestrel; Macrophages; Membrane Proteins; Mifepristone; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; Scavenger Receptors, Class B; Tetradecanoylphorbol Acetate; Up-Regulation | 1996 |
Endometrial effects of RU486 in primates--antiproliferative action despite signs of estrogen action and increased cyclin-B expression.
Topics: Animals; Base Sequence; Cell Division; Cyclins; DNA Primers; Endometrium; Estradiol; Exons; Female; Genes, Tumor Suppressor; Immunohistochemistry; Levonorgestrel; Macaca fascicularis; Menstrual Cycle; Mifepristone; Mitosis; Polymerase Chain Reaction; Progesterone; Proliferating Cell Nuclear Antigen; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Transcription, Genetic; Uterus | 1996 |
Vascular endothelial growth factor in primate endometrium is regulated by oestrogen-receptor and progesterone-receptor ligands in vivo.
Topics: Animals; Base Sequence; DNA Primers; Endometrium; Endothelial Growth Factors; Estradiol; Female; Gene Expression; Immunohistochemistry; Levonorgestrel; Ligands; Lymphokines; Macaca fascicularis; Menstrual Cycle; Mifepristone; Neovascularization, Physiologic; Polymerase Chain Reaction; Progesterone; Progesterone Congeners; Receptors, Estrogen; Receptors, Progesterone; RNA Splicing; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1997 |
11 beta-substituted 13 beta-ethyl gonane derivatives exhibit reversal of antiprogestational activity.
Topics: Animals; Biological Assay; Female; Gonanes; Hormone Antagonists; Levonorgestrel; Mifepristone; Norpregnadienes; Progestins; Rabbits; Receptors, Glucocorticoid; Receptors, Progesterone | 1998 |
Intrauterine contraceptive devices and antigestagens as emergency contraception.
Topics: Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Danazol; Emergencies; Estrogen Antagonists; Family Planning Services; Female; Health Services Accessibility; Humans; Intrauterine Devices, Copper; Levonorgestrel; Mifepristone; Patient Selection; Progestins; Time Factors | 1997 |
Regulation of monocyte to macrophage differentiation by antiglucocorticoids and antioxidants.
Topics: Antioxidants; Cell Differentiation; Female; Glucocorticoids; Humans; Levonorgestrel; Macrophages; Mifepristone; Monocytes | 1998 |
Emergency contraception in clinical practice: global perspectives.
Topics: Adolescent; Adult; Contraception; Contraceptives, Postcoital; Female; Gonadotropin-Releasing Hormone; Health Knowledge, Attitudes, Practice; Humans; Intrauterine Devices; Levonorgestrel; Male; Mifepristone; Patient Compliance; Pregnancy; Pregnancy, Unwanted; Random Allocation; Sex Education | 2000 |
Nonsteroidal progesterone receptor ligands with unprecedented receptor selectivity.
Topics: Alkaline Phosphatase; Animals; Breast Neoplasms; Cell Division; Cell Transformation, Neoplastic; DNA-Binding Proteins; Endometrium; Female; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Levonorgestrel; Macaca fascicularis; Mifepristone; Ovulation; Piperazines; Piperidines; Progesterone; Protein Binding; Pyridazines; Rabbits; Receptors, Androgen; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; Substrate Specificity; Tumor Cells, Cultured | 2000 |
Women's bodies: the site for the ongoing conquest by reproductive technologies.
Topics: Abortion, Induced; Amniocentesis; Contraception; Developing Countries; Equipment and Supplies; Europe; Female; Fertilization in Vitro; Freedom; General Surgery; Hormones; Humans; Immunization; India; International Cooperation; Internationality; Levonorgestrel; Men; Methods; Mifepristone; Morbidity; Netherlands; Personal Autonomy; Pharmaceutical Preparations; Public Policy; Reproductive Techniques, Assisted; Risk; Risk Assessment; Sex Determination Analysis; Sex Preselection; Socioeconomic Factors; Sterilization, Reproductive; United States; Vulnerable Populations; Women; Women's Rights | 1991 |
Up against eugenics: disabled women's challenge to receive reproductive health services.
Topics: Abortion, Induced; Biomedical Research; Civil Rights; Coercion; Contraception; Disabled Persons; Eugenics; Female; Freedom; Health Facilities; Health Services Research; History; Human Experimentation; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Patient Advocacy; Patient Selection; Personal Autonomy; Politics; Prejudice; Reproduction; Research; Research Subjects; Risk; Sexuality; Social Control, Formal; Social Desirability; Stereotyping; Sterilization, Reproductive; United States; Women; Women's Health; Women's Health Services; Women's Rights | 1994 |
Effects of progestins on progesterone synthesis in a stable porcine granulosa cell line: control of transcriptional activity of the cytochrome p450 side-chain cleavage gene.
Topics: Animals; Cell Line; Cell Survival; Cholesterol Side-Chain Cleavage Enzyme; Female; Gene Expression Regulation; Granulosa Cells; Kinetics; Levonorgestrel; Mifepristone; Progesterone; Progestins; Pyridazines; RNA, Messenger; Swine; Transcription, Genetic | 2002 |
Effect of mifepristone and levonorgestrel on expression of steroid receptors in the human Fallopian tube.
Topics: Adult; Biopsy; Fallopian Tubes; Female; Hormone Antagonists; Humans; Immunohistochemistry; Levonorgestrel; Middle Aged; Mifepristone; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger | 2002 |
Transactivation of progestin- and estrogen-responsive promoters by 19-nor progestins in African Green Monkey Kidney CV1 cells.
Topics: Animals; Binding, Competitive; Cell Line; Chloramphenicol O-Acetyltransferase; Chlorocebus aethiops; Estrogens; Gene Expression; Genes, Reporter; Genetic Vectors; Kidney; Levonorgestrel; Mifepristone; Norethindrone; Norpregnenes; Progestins; Promegestone; Promoter Regions, Genetic; Rabbits; Receptors, Progesterone; Response Elements; Transcriptional Activation; Transfection | 2001 |
[Post-coital contraception is changing].
Topics: Contraception; Contraceptives, Postcoital, Hormonal; Contraceptives, Postcoital, Synthetic; Female; Humans; Levonorgestrel; Mifepristone; Treatment Outcome | 2001 |
Post-coital contraception.
Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Developed Countries; Endocrine System; Endometrium; Ethinyl Estradiol; Europe; Family Planning Services; Hormone Antagonists; Hormones; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Mifepristone; Netherlands; Physiology; Progesterone; Progestins; Uterus | 1988 |
[Information on advances in sciences and technology. Advances in contraceptive technology].
Topics: Americas; Biology; Brazil; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Male; Contraceptive Devices, Female; Contraceptives, Oral; Developing Countries; Endocrine System; Family Planning Services; Gossypol; Hormone Antagonists; Hormones; Injections; Intrauterine Devices; Intrauterine Devices, Copper; Latin America; Levonorgestrel; Mifepristone; Physiology; South America; Sterilization, Reproductive; Vasectomy | 1993 |
Current perspectives on emergency contraception.
Topics: Contraception Behavior; Contraceptives, Postcoital; Drug Prescriptions; Emergencies; Ethinyl Estradiol; Female; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Hong Kong; Humans; Intrauterine Devices; Levonorgestrel; Mifepristone; Nonprescription Drugs; Patient Education as Topic; Pregnancy; Pregnancy, Unwanted; Self Administration | 2002 |
Emergency contraception.
Topics: Adult; Clinical Trials as Topic; Contraceptives, Postcoital, Hormonal; Female; Health Services Accessibility; Humans; Levonorgestrel; Mifepristone; Risk Factors; Sexually Transmitted Diseases; Time Factors | 2003 |
Viable cervical pregnancy with levonorgestrel containing intrauterine device, treated successfully with methotrexate and mifepristone.
Topics: Abortifacient Agents; Cervix Uteri; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Ectopic | 2005 |
Contra-contraception: a growing number of conservatives see birth control as part of an ailing culture that overemphasizes sex and devalues human life. Is this the beginning of the next culture war?
Topics: Abortion, Induced; Christianity; Condoms; Contraception; Contraceptives, Postcoital; Cultural Diversity; Europe; Female; Government Regulation; Humans; Internationality; Legislation as Topic; Levonorgestrel; Mifepristone; Morals; Nonprescription Drugs; Politics; Pregnancy; Public Policy; Reproductive Rights; Sex Education; Sexual Abstinence; Sexual Behavior; Sexually Transmitted Diseases; United States; United States Food and Drug Administration; Value of Life | 2006 |
[Emergency contraception].
Topics: Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Female; History, 20th Century; Humans; Intrauterine Devices; Levonorgestrel; Luteolytic Agents; Male; Mifepristone; Time Factors | 2006 |
Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture model.
Topics: Adult; Blastocyst; Cell Culture Techniques; Cells, Cultured; Coculture Techniques; Contraceptive Agents, Female; Endometrium; Female; Gene Expression Regulation; Hormone Antagonists; Humans; Immunohistochemistry; Levonorgestrel; Mifepristone; Trophoblasts | 2007 |
Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model.
Topics: Adult; Biopsy; Cell Culture Techniques; Coculture Techniques; Contraceptives, Oral, Synthetic; Endometrium; Epithelial Cells; Female; Fertility; Humans; Levonorgestrel; Menstrual Cycle; Mifepristone; Models, Biological; Statistics, Nonparametric; Young Adult | 2009 |
Levonorgestrel antagonism on estrogen-induced pituitary tumors is mediated by progesterone receptors.
Topics: Animals; Binding, Competitive; Carcinogens; Diethylstilbestrol; Hormone Antagonists; Levonorgestrel; Male; Mifepristone; Organ Size; Ovariectomy; Pituitary Gland, Anterior; Pituitary Neoplasms; Progesterone Congeners; Prolactin; Rats; Rats, Inbred F344; Receptors, Androgen; Receptors, Progesterone | 2008 |
Simultaneous determination of mifepristone and monodemethyl-mifepristone in human plasma by liquid chromatography-tandem mass spectrometry method using levonorgestrel as an internal standard: application to a pharmacokinetic study.
Topics: Chromatography, Liquid; Humans; Levonorgestrel; Mifepristone; Reference Standards; Reproducibility of Results; Tandem Mass Spectrometry | 2009 |
Certain progestins prevent the enhancing effect of 17beta-estradiol on NO-mediated inhibition of platelet aggregation by endothelial cells.
Topics: Blood Platelets; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Estradiol; GTP Cyclohydrolase; Hormone Antagonists; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol; Mifepristone; Nitric Oxide; Nitric Oxide Synthase Type III; Norpregnadienes; Platelet Aggregation; Progesterone; Progesterone Congeners; Pterins; Receptors, Glucocorticoid; Receptors, Progesterone; RNA, Messenger; Thrombosis; Time Factors | 2009 |
Levonorgestrel, medroxyprogesterone and progesterone cause a concentration-dependent reduction in endometrial cancer (Ishikawa) cell density, and high concentrations of progesterone and mifepristone act in synergy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Drug Synergism; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Medroxyprogesterone; Mifepristone; Progesterone; Progestins; Receptors, Progesterone | 2009 |
[Emergency contraception ].
Topics: Adolescent; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Mifepristone; Norgestrel; Time Factors | 2008 |
Towards more effective emergency contraception?
Topics: Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Mifepristone; Norpregnadienes; Ovulation; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
Progesterone and levonorgestrel regulate expression of 17βHSD-enzymes in progesterone receptor positive breast cancer cell line T47D.
Topics: 17-Hydroxysteroid Dehydrogenases; Breast Neoplasms; Cell Line, Tumor; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Mifepristone; Progesterone; Receptors, Progesterone | 2012 |
Emergency contraception.
Topics: China; Contraception, Postcoital; Contraceptive Agents; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Ethinyl Estradiol; European Union; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Mifepristone; Norpregnadienes; Ovulation; Pregnancy; Pregnancy, Ectopic; Receptors, Progesterone; Time Factors | 2013 |
Transcriptomic and physiological changes in Eastern Mosquitofish (Gambusia holbrooki) after exposure to progestins and anti-progestagens.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Animal Fins; Animals; Cyprinodontiformes; Female; Fish Proteins; Gas Chromatography-Mass Spectrometry; Hedgehog Proteins; In Situ Hybridization; Levonorgestrel; Male; Microarray Analysis; Mifepristone; Progestins; Solid Phase Extraction; Transcriptome; Water Pollutants, Chemical | 2016 |
Repeated use of mifepristone and levonorgestrel and their effect on the ovarian function in mice.
Topics: Animals; Contraceptive Agents, Female; Estrous Cycle; Female; Levonorgestrel; Mice; Mice, Inbred ICR; Mifepristone; Ovary; Receptors, FSH; Receptors, LH; RNA, Messenger | 2016 |
Involvement of glucocorticoid and mineralocorticoid receptors in lipid accumulation and depressed G6PD activity in the livers of rats treated with postpartum oral estrogen-progestin.
Topics: Animals; Contraceptives, Oral, Hormonal; Estrogens; Ethinyl Estradiol; Female; Glucose; Glucosephosphate Dehydrogenase; Levonorgestrel; Lipid Metabolism; Liver; Mifepristone; Mineralocorticoid Receptor Antagonists; Pregnancy; Progestins; Rats; Rats, Wistar; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spironolactone | 2019 |
Clinical evaluation of high-intensity focused ultrasound ablation combined with mifepristone and levonorgestrel-releasing intrauterine system to treat symptomatic adenomyosis.
Topics: Adenomyosis; Child; Dysmenorrhea; Female; High-Intensity Focused Ultrasound Ablation; Humans; Levonorgestrel; Mifepristone | 2023 |